128
Participants
Start Date
September 4, 2020
Primary Completion Date
October 30, 2020
Study Completion Date
October 30, 2020
Viruxal Oral and Nasal Spray
Viruxal Oral and Nasal Spray is a Class I CE marked medical device manufactured by Kerecis hf. The Device contains Omega3 Viruxide. The main components in Omega3 Viruxide are Neem oil and St. John's Wort oil. The Device is administered from a pressurized canister into the oral and nasal cavity, where it creates a physical barrier for temporary protection of the mucosal tissue.
Placebo
The placebo will be a similar spray containing saline only.
National Hospital of Iceland (Landspítali), Reykjavik
Lead Sponsor
Kerecis Ltd.
INDUSTRY